{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:04:53Z","timestamp":1793329493717,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jconrel.2016.08.018","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T06:00:41Z","timestamp":1472018441000},"page":"92-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Materials technology in drug eluting balloons: Current and future perspectives"],"prefix":"10.1016","volume":"239","author":[{"given":"Gordon Minru","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan Siang","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie Liang","family":"Phua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Ni","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbu","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Foin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.08.018_bb0005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejpb.2015.08.010","article-title":"In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons","volume":"96","author":"Kempin","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0010","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2014.05.011","article-title":"Drug-eluting biostable and erodible stents","volume":"193","author":"Huang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCINTERVENTIONS.109.873703","article-title":"Drug-eluting balloon: the comeback kid?","volume":"2","author":"Waksman","year":"2009","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0030","first-page":"191","article-title":"First optical coherence tomography follow-up of coronary bifurcation lesions treated by drug-eluting balloons","volume":"27","author":"Sgueglia","year":"2015","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrcardio.2013.165","article-title":"Drug-coated balloon therapy in coronary and peripheral artery disease","volume":"11","author":"Byrne","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0040","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis","volume":"119","author":"Unverdorben","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0045","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study","volume":"59","author":"Rittger","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0050","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCINTERVENTIONS.112.969972","article-title":"Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials","volume":"5","author":"Cassese","year":"2012","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0055","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jacc.2014.07.960","volume":"64","author":"Laird","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1583\/11-3690.1","article-title":"Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial","volume":"19","author":"Katsanos","year":"2012","journal-title":"J. Endovasc. Ther."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0065","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ejrad.2014.11.037","article-title":"Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472)","volume":"84","author":"Kitrou","year":"2015","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0070","article-title":"Endovascular today - drug-coated balloons: what's their role in AV access?","author":"Spiliopoulos","year":"2015","journal-title":"Endovasc. Today"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0075","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1039\/C4RA12524J","article-title":"Usage of different vessel models in a flow-through cell: in vitro study of a novel coated balloon catheter","volume":"5","author":"Bandomir","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0080","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.addr.2006.01.021","article-title":"Zotarolimus (ABT-578) eluting stents","volume":"58","author":"Burke","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0085","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.RES.86.8.879","article-title":"Arterial paclitaxel distribution and deposition","volume":"86","author":"Creel","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0090","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1073\/pnas.0400918101","article-title":"Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel","volume":"101","author":"Levin","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0095","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIRCINTERVENTIONS.110.960260","article-title":"Vascular response to zotarolimus-coated balloons in injured superficial femoral arteries of the familial hypercholesterolemic swine","volume":"4","author":"Granada","year":"2011","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0100","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.113.002051","article-title":"Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy","volume":"127","author":"Kolachalama","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2009.11.007","article-title":"Lesion complexity determines arterial drug distribution after local drug delivery","volume":"142","author":"Tzafriri","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0110","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jcin.2015.03.020","article-title":"Impact of paclitaxel dose on tissue pharmacokinetics and vascular healing: a comparative drug-coated balloon study in the familial hypercholesterolemic swine model of superficial femoral In-stent restenosis","volume":"8","author":"Gongora","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0115","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jcin.2014.05.008","article-title":"Drug delivering technology for endovascular management of infrainguinal peripheral artery disease","volume":"7","author":"Sarode","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083992","article-title":"In vitro determination of drug transfer from drug-coated balloons","volume":"8","author":"Seidlitz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000117","article-title":"Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing","volume":"1","author":"Granada","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijpharm.2010.02.013","article-title":"Understanding the structure and stability of paclitaxel nanocrystals","volume":"390","author":"Deng","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jconrel.2012.07.004","article-title":"Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug","volume":"162","author":"Carlyle","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2013.01.053","article-title":"Crystalline coating of rapamycin onto a stent: process development and characterization","volume":"445","author":"Farah","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0145","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","article-title":"Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis","volume":"110","author":"Scheller","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0150","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jcin.2013.04.013","article-title":"Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model","volume":"6","author":"Buszman","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0155","first-page":"1733","article-title":"SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study","volume":"60","author":"Wohrle","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0160","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0165","article-title":"Dextran sulfate as a drug delivery platform for drug-coated balloons: preparation, characterization, in vitro drug elution, and smooth muscle cell response","author":"Lamichhane","year":"2015","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.actbio.2015.09.036","article-title":"Preparation, characterization, in vitro drug release, and cellular interactions of tailored paclitaxel releasing polyethylene oxide films for drug-coated balloons","volume":"29","author":"Anderson","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0175","doi-asserted-by":"crossref","first-page":"J161","DOI":"10.4244\/EIJV6SUPJA28","article-title":"Drug-eluting balloons and bifurcations, a new future?","volume":"6","author":"Stella","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ccd.24995","article-title":"Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model","volume":"83","author":"Yazdani","year":"2014","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02641882","article-title":"Peripheral angioplasty balloon technology","volume":"16","author":"Matsumoto","year":"1993","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0190","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jbm.b.33414","article-title":"Characterization of Pebax angioplasty balloon surfaces with AFM, SEM, TEM, and SAXS","volume":"104","author":"Warner","year":"2016","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0376-7388(98)00090-8","article-title":"Pervaporation of aqueous ester solutions through hydrophobic poly(ether-block-amide) copolymer membranes","volume":"146","author":"Djebbar","year":"1998","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0200","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1021\/la00017a047","article-title":"Dynamic wetting and contact-angle hysteresis of polymer surfaces studies with the modified Wilhelmy balance method","volume":"10","author":"Tretinnikov","year":"1994","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0205","first-page":"5","article-title":"Drug Delivery Systems for Vascular Disease Therapy","author":"Subbu","year":"2012"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0210","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/CIRCULATIONAHA.110.936922","article-title":"Drug-coated balloons for the prevention of vascular restenosis","volume":"121","author":"Gray","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0215","first-page":"567","article-title":"Paclitaxel-coated balloons - survey of preclinical data","volume":"58","author":"Schnorr","year":"2010","journal-title":"Minerva Cardioangiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MCA.0b013e3283030b26","article-title":"Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries","volume":"19","author":"Posa","year":"2008","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.33590\/emjintcardiol\/10312835","article-title":"Update on drug-eluting balloons for percutaneous coronary interventions","volume":"1","author":"Vaquerizo","year":"2013","journal-title":"EMJ Int. Cardiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0230","first-page":"110","article-title":"In vitro evaluation of cytocompatibility of shellac as coating for intravascular devices","volume":"26","author":"Kirsten Peters","year":"2012","journal-title":"Trends Biomater. Artif. Organs"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0235","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4244\/EIJV7I6A116","article-title":"Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipient","volume":"7","author":"Radke","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425247.2016.1154530","article-title":"An update on the clinical use of drug-coated balloons in percutaneous coronary interventions","author":"Cheng","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116080","article-title":"Correlating coating characteristics with the performance of drug-coated balloons\u2013a comparative in vitro investigation of own established hydrogel- and ionic liquid-based coating matrices","volume":"10","author":"Kaule","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0255","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s11095-007-9284-6","article-title":"Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery","volume":"24","author":"van Vlerken","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0260","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jcin.2015.03.020","article-title":"Impact of paclitaxel dose on tissue pharmacokinetics and vascular healing a comparative drug-coated balloon study in the familial hypercholesterolemic swine model of superficial femoral In-stent restenosis","volume":"8","author":"Gongora","year":"2015","journal-title":"J. Am. Coll. Cardiol. Intv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RLI.0b013e31820577df","article-title":"Dose response to paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model","volume":"46","author":"Kelsch","year":"2011","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0270","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0275","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.RVI.0000052296.26939.4c","article-title":"Pathologic evaluation of a spherical polyvinyl alcohol embolic agent in a porcine renal model","volume":"14","author":"Siskin","year":"2003","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0280","doi-asserted-by":"crossref","first-page":"B83","DOI":"10.1016\/j.jacc.2014.07.333","article-title":"Detection of paclitaxel contamination resulting from the simulated clinical use of drug coated balloon catheters","volume":"64","author":"Ward","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0285","doi-asserted-by":"crossref","first-page":"19347","DOI":"10.1073\/pnas.1115945108","article-title":"In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid\u2013polymeric nanoparticles","volume":"108","author":"Chan","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10717540802481307","article-title":"New approach for local delivery of rapamycin by bioadhesive PLGA-carbopol nanoparticles","volume":"16","author":"Zou","year":"2009","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0295","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1161\/01.CIR.94.6.1441","article-title":"Local intraluminal infusion of biodegradable polymeric nanoparticles a novel approach for prolonged drug delivery after balloon angioplasty","volume":"94","author":"Guzman","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0300","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1208\/ps040441","article-title":"Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy","volume":"4","author":"Westedt","year":"2002","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0305","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0310","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4244\/EIJV9I1A21","article-title":"Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter","volume":"9","author":"Lemos","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0315","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijpharm.2013.07.003","article-title":"Sirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: a comparison of phospholipid micelles and liposomes","volume":"455","author":"Haeri","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0320","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1007\/s11095-013-1058-8","article-title":"The potential efficacy of R8-modified paclitaxel-loaded liposomes on pulmonary arterial hypertension","volume":"30","author":"Yin","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0325","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.biomaterials.2007.01.014","article-title":"Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles","volume":"28","author":"Lee","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.08.018_bb0330","first-page":"1","article-title":"Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus","volume":"0","author":"Yu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0335","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/CIRCINTERVENTIONS.113.000195","article-title":"Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation","volume":"6","author":"Gasper","year":"2013","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0340","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/157489209789206869","article-title":"Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery","volume":"4","author":"Fu","year":"2009","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0345","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/clc.20066","article-title":"Systemic nanoparticle paclitaxel (nab-paclitaxel) for In-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study","volume":"30","author":"Margolis","year":"2007","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.jconrel.2016.08.018_bb0350","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/eurheartj\/ehp259","article-title":"Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents","volume":"31","author":"Camici","year":"2010","journal-title":"Eur. Heart J."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916305399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916305399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T20:35:09Z","timestamp":1692477309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916305399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":70,"alternative-id":["S0168365916305399"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.08.018","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Materials technology in drug eluting balloons: Current and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}